Abstract
The CRISPR/Cas9 system allows for site-specific gene editing and genome engineering of primary human cells. Here we describe methods for gene editing and genome engineering of B cells isolated from human peripheral blood mononuclear cells using CRISPR/Cas9. Editing frequencies of up to 90% and integration rates greater than 60% can be achieved with this method.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KGC, Dörner T et al (2006) Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6(10):741–750
Slifka MK, Antia R, Whitmire JK, Ahmed R (1998) Humoral immunity due to long-lived plasma cells. Immunity 8(3):363–372
Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA et al (1992) Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176(6):1543–1550
Fusil F, Calattini S, Amirache F, Mancip J, Costa C, Robbins JB et al (2015) A lentiviral vector allowing physiologically regulated membrane-anchored and secreted antibody expression depending on B-cell maturation status. Mol Ther 23(11):1734–1747
Luo XM, Maarschalk E, O’Connell RM, Wang P, Yang L, Baltimore D (2008) Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood 113(7):1422–1431
Johnson MJ, Laoharawee K, Lahr WS, Webber BR, Moriarity BS (2018) Engineering of primary human B cells with CRISPR/Cas9 targeted nuclease. Sci Rep 8(1):12144
Hung KL, Meitlis I, Hale M, Chen C-Y, Singh S, Jackson SW et al (2018) Engineering protein-secreting plasma cells by homology-directed repair in primary human B cells. Mol Ther 26(2):456–467
Alt-R CRISPR-Cas9 System User Guide. https://sfvideo.blob.core.windows.net/sitefinity/docs/default-source/user-guide-manual/alt-r-crispr-cas9-user-guide-ribonucleoprotein-transfections-recommended.pdf?sfvrsn=1c43407_24. Accessed 11 Jun 2019
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Laoharawee, K., Johnson, M.J., Moriarity, B.S. (2020). CRISPR/Cas9-Mediated Genome Engineering of Primary Human B Cells. In: Sioud, M. (eds) RNA Interference and CRISPR Technologies. Methods in Molecular Biology, vol 2115. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0290-4_24
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0290-4_24
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0289-8
Online ISBN: 978-1-0716-0290-4
eBook Packages: Springer Protocols